Early Safety and Efficacy of Sapien 3 20 mm Transcatheter Heart Valve Implantation in Small Japanese Body Size

  • Kentaro Meguro Department of Cardiovascular Medicine, Kitasato University, Sagamihara, Kanagawa, Japan
  • Ryota Kakizaki Department of Cardiovascular Medicine, Kitasato University, Sagamihara, Kanagawa, Japan
  • Takuya Hashimoto Department of Cardiovascular Medicine, Kitasato University, Sagamihara, Kanagawa, Japan
  • Tomoyoshi Yanagisawa Department of Cardiovascular Medicine, Kitasato University, Sagamihara, Kanagawa, Japan
  • Toshimi Koitabashi Department of Cardiovascular Medicine, Kitasato University, Sagamihara, Kanagawa, Japan
  • Tadashi Kitamura Department of Cardiovascular Surgery, Kitasato University, Sagamihara, Kanagawa, Japan
  • Junya Ako Department of Cardiovascular Medicine, Kitasato University, Sagamihara, Kanagawa, Japan

Abstract

Background: Transcatheter aortic valve implantation (TAVI) is effective in treating severe aortic stenosis in inoperable or high-risk surgical patients, however, the little is known about outcomes after Sapien 3 20 mm transcatheter heart valve (THV) implantation. The purpose of this study was to investigate the short term outcomes of Sapien 3 20 mm THV implantation in Japanese people with a small body size.

Methods: We retrospectively collected the hospital records of consecutive patients who underwent TAVI using the Sapien 3 20 mm THV between October 2016 and March 2017. Clinical and echocardiographic data from before and one week after TAVI were collected.

Results: Six Japanese patients (all female, mean age 89 ± 5 years, body surface area [BSA] 1.29 ± 0.16m2) received a Sapien 3 20 mm THV. All the procedures were feasible and successful, and the 30-day mortality rate was 0%. The functional class and the echocardiographic findings significantly improved (aortic valve area, 0.5 ± 0.1 cm2 to 0.8 ± 0.1cm2; mean pressure gradient, 55 ± 15 mmHg to 19 ± 7 mmHg;
P = .043, respectively). However, the values of the indexed effective orifice area in all patients after Sapien 3 20 mm THV implantation were less than 0.85 cm2/m2, suggesting prosthesis-patient mismatch (PPM).

Conclusions: The implantation of a Sapien 3 20 mm THV was safe and effective in high surgical risk elderly Japanese patients with a small body size. PPM after Sapien 3 20mm THV may be prevalent among Asians with small body sizes. Careful clinical follow-up will be necessary after Sapien 3 20 mm THV implantation.

References

Binder RK, Rodes-Cabau J, Wood DA, et al. 2012 Edwards SAPIEN 3 valve. EuroIntervention 8 Suppl Q:Q83-7.

Dvir D, Webb JG, Bleiziffer S, et al. 2014 Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. Jama 312:162-70.

Ewe SH, Muratori M, Delgado V, et al. 2011 Hemodynamic and clinical impact of prosthesis-patient mismatch after transcatheter aortic valve implantation. J Am Coll Cardiol 58:1910-8.

Kappetein AP, Head SJ, Genereux P, et al. 2012 Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60:1438-54.

Kodali S, Thourani VH, White J, et al. 2016 Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J 37:2252-62.

Leon MB, Smith CR, Mack M, et al. 2010 Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597-607.

Loyalka P, Nascimbene A, Schechter M, et al. 2016 Transcatheter aortic valve implantation with a Sapien 3 Commander 20 mm valves in patients with degenerated 19 mm bioprosthetic aortic valve. Catheter Cardiovasc Interv

Meguro K, Lellouche N, Yamamoto M, et al. 2013 Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the CoreValve. Am J Cardiol 111:1778-83.

Pibarot P, Weissman NJ, Stewart WJ, et al. 2014 Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis. J Am Coll Cardiol 64:1323-34.

Puri R, Byrne J, Muller R, et al. 2017 Transcatheter aortic valve implantation in patients with small aortic annuli using a 20 mm balloon-expanding valve. Heart 103:148-153.

Reardon MJ, Van Mieghem NM, Popma JJ, et al. 2017 Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 376:1321-1331.

Sawaya FJ, Spaziano M, Lefevre T, et al. 2016 Comparison between the SAPIEN S3 and the SAPIEN XT transcatheter heart valves: A single-center experience. World J Cardiol 8:735-745.

Smith CR, Leon MB, Mack MJ, et al. 2011 Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187-98.

Takagi H, Umemoto T. 2015 Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation. Ann Thorac Surg 101:872-80.

Theron A, Pinto J, Grisoli D, et al. 2017 Patient-prosthesis mismatch in new generation trans-catheter heart valves: a propensity score analysis. Eur Heart J Cardiovasc Imaging

Thourani VH, Kodali S, Makkar RR, et al. 2016 Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet 387:2218-25.

Tops LF, Wood DA, Delgado V, et al. 2008 Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 1:321-30.

Watanabe Y, Hayashida K, Lefevre T, et al. 2014 Transcatheter aortic valve implantation in patients of small body size. Catheter Cardiovasc Interv 84:272-80.

Watanabe Y, Hayashida K, Takayama M, et al. 2015 First direct comparison of clinical outcomes between European and Asian cohorts in transcatheter aortic valve implantation: the Massy study group vs. the PREVAIL JAPAN trial. J Cardiol 65:112-6.

Webb J, Gerosa G, Lefevre T, et al. 2014 Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol 64:2235-43.

Published
2018-08-14
Section
Articles